Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 3Phase NA 1Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 4Gastrointestinal 3Lymphoid 1

Conditions

Stomach Neoplasms 2Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Familial primary gastric lymphoma 1Atrophy 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Clarithromycin × Gastrointestinal × Clear all
NCT02407119 2023-11-09

Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

National Cancer Center, Korea

Phase 3 Active not recruiting
470 enrolled
Gastrointestinal

Atrophy, Stomach Neoplasms

NCT00003617 2013-09-20

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00154440 2007-03-26

Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation

Technische Universität Dresden

Phase 3 Unknown
200 enrolled
GastrointestinalLymphoid

Familial primary gastric lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡